ADVANCED BILIARY TRACT CANCER
Clinical trials for ADVANCED BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of drugs shows promise for bile duct cancer
Disease control OngoingThis study tests a new drug combination for people with advanced biliary tract cancer (bile duct cancer) who haven't had treatment before. About 93 participants will receive either a standard chemotherapy plus two immunotherapy drugs, or the same plus an extra experimental drug. …
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immunotherapy combo shows promise in bile duct cancer trial
Disease control OngoingThis phase 3 trial tests whether adding the immunotherapy drug durvalumab to standard chemotherapy (gemcitabine plus cisplatin) helps people with advanced biliary tract cancer live longer. About 810 participants received either durvalumab or a placebo alongside chemo. The study m…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Immunotherapy duo takes on rare cancers
Disease control OngoingThis Phase 2 trial is testing whether combining two immunotherapy drugs, ipilimumab and nivolumab, can shrink or control rare cancers that are known to respond to immunotherapy. The study includes 240 people with advanced biliary tract, neuroendocrine, gynecologic, or MSI-H solid…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Olivia Newton-John Cancer Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for bile duct cancer: targeted chemo combo shows promise in early trial
Disease control OngoingThis Phase 2 study is testing a combination of three drugs—nanoliposomal irinotecan, fluorouracil, and leucovorin—in 48 adults with advanced biliary tract cancer that has progressed after initial chemotherapy. The main goal is to see if the treatment can stop the cancer from grow…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New combo therapy targets Hard-to-Treat bile duct cancer
Disease control OngoingThis study tests whether combining two drugs—regorafenib (a targeted therapy) and durvalumab (an immunotherapy)—can help people with advanced biliary tract cancer that has stopped responding to chemotherapy. About 40 participants will receive both drugs to see if the combination …
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug cocktail shows promise for tough bile duct cancer
Disease control OngoingThis phase 2 trial tests a combination of two drugs, lenvatinib and paclitaxel, in 51 adults with advanced biliary tract cancer that has worsened after standard gemcitabine treatment. The goal is to see if the combo can shrink tumors and slow the disease. Participants take lenvat…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC